Thank you, Celeste. I'll begin with some additional financial details on the second quarter. For the quarter, revenue was down 2.1% versus the same period last year. Adjusting for the flooring divestiture, net revenue was up 2.8% year on year. Currency had a negative impact of 1.2%, and the net impact of acquisitions and divestitures decreased revenue by 1.3%. Adjusting for those items, organic revenue was up 0.4%, with pricing up 0.7% and volume down 0.3% year on year. Adjusted gross profit margin was 32.2%, up 110 basis points versus last year, driven by cost savings, the impact of acquisitions and divestitures, and targeted pricing actions. Adjusted selling, general, and administrative expense was up 2% year on year. Adjusting for the net impact of acquisitions and divestitures, adjusted SG&A was flat year on year, reflecting strong expense management. Adjusted EBITDA for the quarter of $166 million was up 5% year on year, driven principally by targeted pricing actions, cost savings efforts, and the net benefit from acquisitions and divestitures. Adjusted earnings per share of $1.18 was up 5% versus the second quarter of 2024 due to higher net income and lower shares outstanding. Second quarter operating cash flow of $111 million increased $29 million or 36% year on year. Cash flow from operations was also up versus the first quarter, reflecting higher net income and a slight improvement in working capital. Net debt to adjusted EBITDA decreased sequentially from 3.5 times to 3.4x at the end of the second quarter, reflecting growth in EBITDA as well as lower debt balances as a result of improved cash flow. We expect to continue to further reduce our leverage ratio in the second half. During the second quarter, we repurchased 300,000 shares, bringing the year-to-date total to approximately 1 million shares. With that, let me now turn to our updated guidance for the 2025 fiscal year. As a result of our strong financial performance and the assumptions that Celeste laid out earlier, we are updating our previously communicated guidance for fiscal 2025 as follows. Net revenue is now expected to be down 2% to 3% year on year. We still expect organic revenue to be flat to up 2% year on year, and we now expect foreign exchange to adversely impact revenue by between 1-1.5% year on year. Adjusted EBITDA is now expected to be in the range of $615 million to $630 million, equating to growth of 4% to 6% year on year. We now expect fully diluted shares outstanding for fiscal 2025 to be in the range of 55 million to 56 million shares. Combined, these assumptions now result in full-year adjusted EPS in the range of $4.10 to $4.30, equating to year-on-year growth of between 7-12%. We continue to expect full-year operating cash flow to be between $300 million and $325 million. Finally, we would expect third-quarter EBITDA in the range of $165 million to $175 million. Let me turn the call back over to Celeste.